{
  "authors": [
    {
      "author": "Kostas Stylianou"
    },
    {
      "author": "George Tsirakis"
    },
    {
      "author": "Elpis Mantadakis"
    },
    {
      "author": "Irini Xylouri"
    },
    {
      "author": "Andreas Foudoulakis"
    },
    {
      "author": "Eleftheria Vardaki"
    },
    {
      "author": "Irene Katsipi"
    },
    {
      "author": "Eugene Daphnis"
    },
    {
      "author": "George Samonis"
    }
  ],
  "doi": "10.1186/1757-1626-2-6611",
  "publication_date": "2009-10-16",
  "id": "EN118424",
  "url": "https://pubmed.ncbi.nlm.nih.gov/19829833",
  "source": "Cases journal",
  "source_url": "",
  "licence": "CC BY",
  "language": "en",
  "type": "pubmed",
  "description": "",
  "text": "We describe the case of a 17-year-old female with refractory thrombotic thrombocytopaenic purpura. The patient was receiving a new generation of oral contraceptives for dysmenorrhoea and had factor V Leiden. After undergoing prolonged and intense plasma exchange therapy for 40 days and high dose oral corticosteroids therapy for 90 days, our patient recovered fully."
}